These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9222731)

  • 1. The age-related incidences of oesophageal carcinoma in intellectually disabled individuals in institutes in The Netherlands.
    Böhmer CJ; Klinkenberg-Knol EC; Niezen-de Boer RC; Meuwissen SG
    Eur J Gastroenterol Hepatol; 1997 Jun; 9(6):589-92. PubMed ID: 9222731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastro-oesophageal reflux disease in institutionalised intellectually disabled individuals.
    Böhmer CJ; Niezen-de Boer MC; Klinkenberg-Knol EC; Nadorp JH; Meuwissen SG
    Neth J Med; 1997 Oct; 51(4):134-9. PubMed ID: 9446923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal trends of Barrett's oesophagus and gastro-oesophageal reflux and related oesophageal cancer over a 10-year period in England and Wales and associated proton pump inhibitor and H2RA prescriptions: a GPRD study.
    Alexandropoulou K; van Vlymen J; Reid F; Poullis A; Kang JY
    Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):15-21. PubMed ID: 23022985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adam, Eve and the reflux enigma: age and sex differences across the gastro-oesophageal reflux spectrum.
    Royston C; Bardhan KD
    Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):634-639. PubMed ID: 28151751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux.
    Solaymani-Dodaran M; Logan RF; West J; Card T; Coupland C
    Gut; 2004 Aug; 53(8):1070-4. PubMed ID: 15247170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of gastro-oesophageal reflux disease based on non-specific symptoms in institutionalized, intellectually disabled individuals.
    Böhmer CJ; Klinkenberg-Knol EC; Niezen-de Boer RC; Meuwissen SG
    Eur J Gastroenterol Hepatol; 1997 Feb; 9(2):187-90. PubMed ID: 9058632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence of adenocarcinoma in Barrett's esophagus in an institutionalized population.
    van Blankenstein M; Böhmer CJ; Hop WC
    Eur J Gastroenterol Hepatol; 2004 Sep; 16(9):903-9. PubMed ID: 15316416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolution and outcome of surveillance of Barrett's oesophagus over four decades in a UK District General Hospital.
    Royston C; Caygill C; Charlett A; Bardhan KD
    Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1365-1373. PubMed ID: 27571366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epidemic of oesophageal carcinoma: Where are we now?
    Thrift AP
    Cancer Epidemiol; 2016 Apr; 41():88-95. PubMed ID: 26851752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenocarcinoma and Barrett's oesophagus. A clinico-pathological study.
    Moghissi K; Sharpe DA; Pender D
    Eur J Cardiothorac Surg; 1993; 7(3):126-31. PubMed ID: 8461144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma.
    Lord RV; Frommer DJ; Inder S; Tran D; Ward RL
    Aust N Z J Surg; 2000 Jan; 70(1):26-33. PubMed ID: 10696939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study.
    Zagari RM; Fuccio L; Wallander MA; Johansson S; Fiocca R; Casanova S; Farahmand BY; Winchester CC; Roda E; Bazzoli F
    Gut; 2008 Oct; 57(10):1354-9. PubMed ID: 18424568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of gastroesophageal reflux disease in institutionalized intellectually disabled individuals.
    Böhmer CJ; Niezen-de Boer MC; Klinkenberg-Knol EC; Devillé WL; Nadorp JH; Meuwissen SG
    Am J Gastroenterol; 1999 Mar; 94(3):804-10. PubMed ID: 10086670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Barrett's oesophagus, oesophageal adenocarcinoma and reflux oesophagitis and the use of nitrates and asthma medications.
    Ladanchuk TC; Johnston BT; Murray LJ; Anderson LA;
    Scand J Gastroenterol; 2010 Dec; 45(12):1397-403. PubMed ID: 20626305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of oesophageal adenocarcinoma in individuals with Barrett's oesophagus.
    Holmberg D; Ness-Jensen E; Mattsson F; El-Serag HB; Lagergren J
    Eur J Cancer; 2017 Apr; 75():41-46. PubMed ID: 28214656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review: Barrett's oesophagus in Taiwan.
    Chen PH
    J Gastroenterol Hepatol; 1997 Jun; 12(6):S19-22. PubMed ID: 9195407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: Barrett's oesophagus and carcinoma in Japan.
    Hongo M
    Aliment Pharmacol Ther; 2004 Dec; 20 Suppl 8():50-4. PubMed ID: 15575874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: Barrett's oesophagus and associated adenocarcinoma--a UK perspective.
    Fitzgerald RC
    Aliment Pharmacol Ther; 2004 Dec; 20 Suppl 8():45-9. PubMed ID: 15575873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
    Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
    Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary inflammatory index and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study.
    Shivappa N; Hebert JR; Anderson LA; Shrubsole MJ; Murray LJ; Getty LB; Coleman HG
    Br J Nutr; 2017 May; 117(9):1323-1331. PubMed ID: 28571591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.